PATIENT SATISFACTION AND SENSORY ATTRIBUTES OF TWO COMBINATION NASAL SPRAYS (OLOPATADINE HYDROCHLORIDE/MOMETASONE FUROATE MONOHYDRATE AND AZELASTINE HYDROCHLORIDE/FLUTICASONE PROPIONATE) FOR TREATMENT OF ALLERGIC RHINITIS IN AUSTRALIA

被引:0
|
作者
Fifer, Simon [1 ]
Toh, Lili [1 ]
Young, Katherine [2 ]
Morgan, Claire [2 ]
Aggarwal, Vineet [3 ]
Borade, Dhammraj [3 ]
Gordonsmith, Roger [4 ]
Wu, Wen [3 ]
机构
[1] Community & Patient Preference Res CaPPRe, Sydney, NSW, Australia
[2] Seqirus Pty Ltd, Parkville, Vic, Australia
[3] Glenmark Pharmaceut Ltd, Mumbai, Maharashtra, India
[4] Glenmark Pharmaceut Europe, Watford, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P55
引用
收藏
页码:18 / 19
页数:9
相关论文
共 40 条
  • [1] Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study
    Fifer, Simon
    Toh, Lili
    Barkate, Hanmant
    Aggarwal, Vineet
    Borade, Dhammraj
    Gordonsmith, Roger Hereward
    Wu, Wen
    Morgan, Claire
    Young, Katherine
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 141 - 151
  • [2] Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: Olopatadine hydrochloride versus mometasone furoate monohydrate
    Patel, Deepen
    Garadi, Rekha
    Brubaker, Michael
    Conroy, Peter J.
    Kaji, Yoshiko
    Crenshaw, Krista
    Whitling, Anna
    Wall, G. Michael
    ALLERGY AND ASTHMA PROCEEDINGS, 2007, 28 (05) : 592 - 599
  • [3] Efficacy and safety of the combination nasal spray olopatadine hydrochloride-mometasone furoate in the treatment of allergic rhinitis
    Klimek L.
    Klimek F.
    Bergmann C.
    Hagemann J.
    Cuevas M.
    Becker S.
    Allergo Journal International, 2024, 33 (1) : 9 - 19
  • [4] Efficacy and Safety of the Combination Nasal Spray Olopatadine Hydrochloride-mometasone Furoate in the Treatment of allergic Rhinitis
    Klimek, Ludger
    Klimek, Felix
    Bergmann, Christoph
    Hagemann, Jan
    Cuevas, Mandy
    Becker, Sven
    ALLERGO JOURNAL, 2024, 33 (03) : 45 - 49
  • [5] Efficacy and Safety of the Combination Nasal Spray Olopatadine Hydrochloride-Mometasone Furoate in the Treatment of allergic Rhinitis
    Klimek, Ludger
    Klimek, Felix
    Bergmann, Christoph
    Hagemann, Jan
    Cuevas, Mandy
    Becker, Sven
    ALLERGO JOURNAL, 2024, 33 (01) : 31 - 43
  • [6] Efficacy and Safety of the Combination Nasal Spray Olopatadine Hydrochloride-Mometasone Furoate in the Treatment of allergic Rhinitis
    Klimek, L.
    Klimek, F.
    Bergmann, C.
    Hagemann, J.
    Cuevas, M.
    Becker, S.
    ALLERGOLOGIE, 2024, 47 (04)
  • [7] Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis
    Ratner, Paul H.
    Hampel, Frank
    Van Bavel, Julius
    Amar, N. J.
    Daftary, Pramila
    Wheeler, William
    Sacks, Harry
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : 74 - 81
  • [8] A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis
    Yanez, Anahi
    Dimitroff, Alex
    Bremner, Peter
    Rhee, Chae-Seo
    Luscombe, Graham
    Prillaman, Barbara A.
    Johnson, Neil
    ALLERGY & RHINOLOGY, 2016, 7 (04) : E183 - E192
  • [9] A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis
    Ridolo, Erminia
    Montagni, Marcello
    Melli, Valerie
    Bonzano, Laura
    Incorvaia, Cristoforo
    Canonica, Giorgio Walter
    THERAPEUTIC DELIVERY, 2015, 6 (06) : 653 - 659
  • [10] Efficacy comparison between mometasone furoate combined with azelastine hydrochloride and azelastine hydrochloride alone in treatment of allergic rhinitis with adenoidal hypertrophy in children
    Zhang, Xiangwen
    Su, Renjie
    Peng, Qianhua
    Zhao, Penglong
    Chen, Ruixiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 10762 - 10768